Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy

被引：1
|
作者：
Faraji, Farhoud [1 ]
Cohen, Ezra E. W. [2 ]
Guo, Theresa W. [1 ]
机构：
[1] UC San Diego Hlth, Gleiberman Head & Neck Canc Ctr, Moores Canc Ctr, Dept Otolaryngol Head & Neck Surg, La Jolla, CA USA
[2] UC San Diego Hlth, Dept Internal Med, Gleiberman Head & Neck Canc Ctr, Moores Canc Ctr,Div Hematol Oncol, La Jolla, CA USA
来源：
TRANSLATIONAL CANCER RESEARCH | 2023年 / 12卷 / 05期
关键词：
Immunotherapy; salvage surgery; head and neck squamous cell carcinoma (HNSCC); HUMAN-PAPILLOMAVIRUS; INVESTIGATORS CHOICE; COMORBIDITY INDEX; MUTATIONAL BURDEN; SURGICAL SALVAGE; PD-1; BLOCKADE; CHECKMATE; 141; OPEN-LABEL; SURVIVAL; CANCER;
D O I：
10.21037/tcr-23-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1353 / 1358
页数：6
相关论文
共 50 条
  • [41] Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinoma
    Hanna, Glenn J.
    Adkins, Douglas R.
    Zolkind, Paul
    Uppaluri, Ravindra
    ORAL ONCOLOGY, 2017, 73 : 65 - 69
  • [42] Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature
    Bossi, Paolo
    Alfieri, Salvatore
    Strojan, Primoz
    Takes, Robert P.
    Lopez, Fernando
    Makitie, Antti
    Saba, Nabil F.
    Pablo Rodrigo, Juan
    Bradford, Carol
    Suarez, Carlos
    Zafereo, Mark
    Forastiere, Arlene A.
    Vermorken, Jan B.
    Quer, Miquel
    Sanabria, Alvaro
    Simo, Ricard
    de Bree, Remco
    Rinaldo, Alessandra
    Ferlito, Alfio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 137 : 84 - 91
  • [43] Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
    Okada, Takuro
    Matsuki, Takashi
    Fushimi, Chihiro
    Okamoto, Isaku
    Sato, Hiroki
    Kondo, Takahito
    Tokashiki, Kunihiko
    Ito, Tatsuya
    Masubuchi, Tatsuo
    Tada, Yuichiro
    Miura, Kouki
    Hanyu, Kenji
    Omura, Go
    Takahashi, Hideki
    Yamashita, Taku
    Oridate, Nobuhiko
    Tsukahara, Kiyoaki
    ANTICANCER RESEARCH, 2022, 42 (10) : 4907 - 4912
  • [44] Comparison of second-line treatments of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    El Rassy, Elie
    Assi, Tarek
    Bakouny, Ziad
    El Karak, Fadi
    Pavlidis, Nicholas
    Ghosn, Marwan
    FUTURE ONCOLOGY, 2019, 15 (08) : 909 - 924
  • [45] Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy
    Bell, R. Bryan
    Gough, Michael J.
    Seung, Steven K.
    Jutric, Zeljka
    Weinberg, Andrew D.
    Fox, Bernard A.
    Crittenden, Marka R.
    Leidner, Rom S.
    Curti, Brendan
    ORAL ONCOLOGY, 2016, 61 : 166 - 176
  • [46] Paradigm Change in First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
    Borcoman, Edith
    Marret, Gregoire
    Le Tourneau, Christophe
    CANCERS, 2021, 13 (11)
  • [47] Immunotherapy for the treatment of perineural spread in cutaneous head and neck squamous cell carcinoma: Time to rethink treatment paradigms
    Nightingale, James
    Gandhi, Mitesh
    Helena, Jonathan
    Bowman, James
    McGrath, Margaret
    Coward, Jermaine
    Porceddu, Sandro
    Ladwa, Rahul
    Panizza, Benedict
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (05): : 1099 - 1105
  • [48] Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinoma
    Weiss, Jared M.
    Bagley, Stephen
    Hwang, Wei-Ting
    Bauml, Joshua
    Olson, Juneko Grilley
    Cohen, Roger B.
    Hayes, David Neil
    Langer, Corey
    CANCER, 2016, 122 (15) : 2350 - 2355
  • [49] The promise of immunotherapy in head and neck squamous cell carcinoma
    Economopoulou, P.
    Agelaki, S.
    Perisanidis, C.
    Giotakis, E. I.
    Psyrri, A.
    ANNALS OF ONCOLOGY, 2016, 27 (09) : 1675 - 1685
  • [50] Chemotherapy postimmunotherapy for recurrent metastatic head and neck squamous cell carcinoma
    Ducoulombier, Agnes
    Guigay, Joel
    Etienne-Grimaldi, Marie-Christine
    Saada-Bouzid, Esma
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (03) : 166 - 177
12345